KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $11.03 $12.67 Friday, 26th Apr 2024 DVAX stock ended at $11.21. This is 0.358% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.09% from a day low at $11.03 to a day high of $11.26.
90 days $11.03 $13.41
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Mar 07, 2016 $16.85 $18.21 $16.52 $17.75 1 454 700
Mar 04, 2016 $17.44 $17.66 $16.60 $17.05 726 600
Mar 03, 2016 $17.50 $17.65 $16.75 $17.13 784 100
Mar 02, 2016 $16.81 $17.98 $16.70 $17.48 830 500
Mar 01, 2016 $16.33 $16.88 $15.80 $16.79 1 276 300
Feb 29, 2016 $17.46 $17.77 $16.01 $16.12 1 094 800
Feb 26, 2016 $17.77 $17.83 $16.68 $17.37 1 326 500
Feb 25, 2016 $18.35 $18.58 $17.37 $17.73 783 500
Feb 24, 2016 $17.90 $18.49 $16.80 $18.22 1 168 100
Feb 23, 2016 $19.28 $20.09 $17.90 $18.05 1 409 700
Feb 22, 2016 $19.84 $20.34 $19.55 $19.59 633 100
Feb 19, 2016 $19.45 $19.88 $18.81 $19.72 532 000
Feb 18, 2016 $20.60 $20.66 $19.50 $19.56 506 200
Feb 17, 2016 $20.12 $20.73 $19.52 $20.51 930 000
Feb 16, 2016 $19.29 $20.20 $19.10 $19.94 1 127 700
Feb 12, 2016 $19.13 $19.93 $18.25 $18.97 703 900
Feb 11, 2016 $17.97 $19.15 $17.85 $18.91 1 055 900
Feb 10, 2016 $18.53 $19.61 $18.27 $18.40 717 700
Feb 09, 2016 $18.13 $19.18 $17.54 $18.21 1 198 500
Feb 08, 2016 $20.39 $20.55 $18.50 $18.83 1 231 700
Feb 05, 2016 $21.79 $22.42 $20.93 $21.05 824 300
Feb 04, 2016 $23.03 $24.13 $21.80 $21.99 807 800
Feb 03, 2016 $23.40 $23.54 $21.88 $22.82 761 200
Feb 02, 2016 $23.55 $23.89 $22.81 $23.36 662 000
Feb 01, 2016 $23.51 $24.90 $23.51 $23.80 908 000
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT